Pharmacy Daily | Safety Update

THE TGA has published the third edition of its Medicines Safety Update which replaces the former Australian Adverse Drug Reactions Bulletin. Issues covered include 61 reports of suspected adverse reactions to sibutramine after preliminary results from a trial which showed higher rates of heart attack and stroke in subjects who were obese or overweight and were using it. “The TGA is reviewing the safety of the product and while that review is ongoing has reinforced existing advice to healthcare professionals to carefully review the sibutramine Product Information before prescribing the product,” the update warns. There’s also a review of reports of drug-induced pancreatitis associated with exanitide (Byetta) and an article emphasising the importance of identifying the AUST L number on the label of complementary medicines suspected of causing adverse reactions.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 04 Jun 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Jun 10